Page 2 - European Network For The Study Of Cholangiocarcinoma News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from European network for the study of cholangiocarcinoma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In European Network For The Study Of Cholangiocarcinoma Today - Breaking & Trending Today

Pembrolizumab plus chemotherapy as first-line treatment for advanced biliary tract cancer

Biliary tract cancers have increased in incidence in many parts of the world, particularly
cases of intrahepatic disease.1,2 The incidence of cholangiocarcinoma varies geographically,
with 1·6 cases per 100 000 people in the USA, for example, but substantially higher
rates in parts of east Asia.2 Most patients present with advanced disease not amenable
to surgery and require systemic therapy. For more than 10 years, gemcitabine and cisplatin
was the internationally accepted first-line treatment for patients with locally advanced
and metastatic biliary tract cancer, as per the ABC-02 study. ....

United States , Gastroenterol Hepatol , European Network For The Study Of Cholangiocarcinoma , European Network , Rev Gastroenterol Hepatol , Res Treat , Drug Administration ,